pulmonx.comHealthcareFunding to Date: $226.39MM
Pulmonx is the developer of the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema.
For more details on financing and valuation for Pulmonx, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
View Enterprise Value for Pulmonx.
To read this article and more news on Pulmonx, register or login.